IQ-AI (IQAI) Share Price, News & Analysis

Company Overview

IQ-AI Limited, through its subsidiaries, provides clinical treatments to patients in the field of medical imaging diagnostics primarily in the United States. It develops ready-to-use software applications for the healthcare industry; and provides technology solutions in the field of kidney stone analysis and prevention, as well as offers consulting services. The company was formerly known as Flying Brands Limited and changed its name to IQ-AI Limited in October 2018. The company was incorporated in 1965 and is based in Saint Helier, Jersey.

Key Stats

• Today's Range: 0.80 to 0.84
• 50-Day Range: 0.75 to 0.94
• 52-Week Range: 0.72 to 2.10
• Volume: 365,612 shs
• Average Volume: 693,857 shs
• Market Capitalization: £1.77 million
• P/E Ratio: N/A
• Dividend Yield: 17.30%
• Price Target: N/A
• Consensus Rating: N/A

IQAI Stock Analysis - Frequently Asked Questions

How have IQAI shares performed this year?

IQ-AI's stock was trading at GBX 1.30 on January 1st, 2025. Since then, IQAI stock has decreased by 38.5% and is now trading at GBX 0.80.
View the best growth stocks for 2025 here.

How were IQ-AI's earnings last quarter?

IQ-AI Limited (LON:IQAI) released its quarterly earnings data on Friday, April, 25th. The company reported ($0.15) EPS for the quarter. IQ-AI had a negative net margin of 77.52% and a negative trailing twelve-month return on equity of 140.75%.

How do I buy shares of IQ-AI?

Shares of IQAI stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What other stocks do shareholders of IQ-AI own?

Based on aggregate information from My MarketBeat watchlists, some other companies that IQ-AI investors own include Meta Platforms (META), Advanced Micro Devices (AMD), Alibaba Group (BABA), Brookline Capital Acquisition (BCAC), Banxa (BNXAF), Crane (CR) and Ford Motor (F).

Company Calendar

• Last Earnings: 4/25/2025
• Today: 5/29/2025

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Medical
• Industry: Health Information Services
• Sub-Industry: N/A
• Current Symbol: LON:IQAI
• CIK: N/A
• Web: www.imagingbiometrics.com
• Phone: N/A
• Fax: N/A
• Employees: 6
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: -77.52%
• Pretax Margin: N/A
• Return on Equity: -140.75%
• Return on Assets: -22.03%

Debt

• Debt-to-Equity Ratio: 8.80
• Current Ratio: 0.68
• Quick Ratio: 1.01

Sales & Book Value

• Annual Sales: £538,190.00
• Price / Sales: 3.30
• Cash Flow: GBX 0.08 per share
• Price / Cash Flow: 10.25
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 221,710,000
• Free Float: N/A
• Market Cap: £1.77 million
• Optionable: Not Optionable
• Beta: 2.25